Navigation Links
Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
Date:8/12/2009

CHAPEL HILL, N.C., Aug. 12 /PRNewswire/ -- Cempra Pharmaceuticals today announced the appointment of John H. Johnson, Chief Executive Officer of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to the company's Board of Directors. Mr. Johnson brings more than 25 years of biopharmaceutical executive and operational management experience, including leadership of successful anti-infective businesses and numerous flagship pharmaceutical products, to his role as an independent member of the Board.

"I've been closely tied to the antibacterial and public health product markets throughout my career in the biopharmaceutical industry, and Cempra's clinical-stage anti-infective programs address an absolutely critical market need for safe, potent antibiotics," said Mr. Johnson. "Cempra is at a turning point in the company's development of its two lead compounds, as both are poised to advance into later stage clinical trials. I look forward to working with Cempra's other Board members and management to enable the success of these much-needed drugs."

Cempra's lead macrolide, CEM-101, will soon enter a Phase 2 clinical trial for moderate to moderately severe community-acquired bacterial pneumonia. Cempra has also initiated an adaptive design Phase 2/3 trial in acute bacterial skin structure infections for CEM-102, an antibiotic with an established record of treating staphylococcal infections, including methicillin-resistant Staphylococcus aureus (MRSA). Cempra recently completed a $46 million Series C financing that will fund the further development of these compounds.

"John's respected reputation, deep knowledge of the antibacterial market and strong business acumen makes him an extremely well-positioned, highly-valued addition to our Board of Directors," said Prabhavathi Fernandes, President and CEO, Cempra Pharmaceuticals. "Following a ve
'/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
3. OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
4. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
5. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
6. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
7. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
8. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
9. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
11. ADVENTRX Pharmaceuticals Announces Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... , ... Argonne, Ill. (Vocus) ... Energy’s (DOE) Argonne National Laboratory and Northwestern University, Evanston, ... in a solution, providing insights for design of bio-inspired dynamically ... million times more massive than the bacteria,” said physicist and ...
(Date:12/16/2009)... for fiscal 2009; on track for positive cash ... /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a biotechnology ... reported financial results for fourth quarter and full-year ... 2009, Microbix reported revenues of $6.08 million, a ... For fourth-quarter 2009, the Company saw revenues increase ...
(Date:12/16/2009)... Germany, December 16 Eppendorf has ... and Verigene(R) SP systems for,infringement of European ... "Method for the,identification and/or the quantification of ... and all imports of the respective products ... authorities are required to confiscate any,violating products. ...
(Date:12/15/2009)... Department of Energy (DOE) bio-energy research centers, has selected ... intellectual property. , ... ... Surety, LLC , the leading provider of data ... BioEnergy Institute (JBEI), one of three Department of Energy ...
Breaking Biology Technology:Argonne Scientists Use Bacteria to Power Simple Machines 2Argonne Scientists Use Bacteria to Power Simple Machines 3Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... 5 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ... that identifies,develops and commercializes differentiated products for patients ... David Allan, Chairman and CEO, at,12:00pm EDT today, ... are invited to discuss the preliminary results obtained ...
... -- Record consolidated revenues of $14.9 million -- ... of $2.3 million - 49% growth ... million credit facility - expands capital resources, -- Reported MIS procedure times of 60 minutes and ... days ...
... MONTREAL, Aug. 5 /PRNewswire-FirstCall/ - ProMetic Life ... has reached an understanding,with a fully integrated, ... and global commercialization of several biopharmaceutical,products in ... to licensing, development and milestone fees as ...
Other Biology Technology:NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER 2AtriCure Reports Record Second Quarter 2008 Financial Results 2AtriCure Reports Record Second Quarter 2008 Financial Results 3AtriCure Reports Record Second Quarter 2008 Financial Results 4AtriCure Reports Record Second Quarter 2008 Financial Results 5AtriCure Reports Record Second Quarter 2008 Financial Results 6AtriCure Reports Record Second Quarter 2008 Financial Results 7AtriCure Reports Record Second Quarter 2008 Financial Results 8Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment 2Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment 3
(Date:12/16/2009)... A University of Maryland School of Medicine researcher will ... nation,s most prominent scientists in the field of stem ... and Preventive Medicine, was chosen by the National Heart, ... of this consortium of national experts, which will be ... center will be funded by a $30 million grant ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...
(Date:12/16/2009)... European Union (EU) member states are spending ... increasingly subjected to unauthorised immigration and illegal ... security and IT-based systems will boost the ... ) ,, New analysis from Frost & ... Market Assessment - European Union , finds ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 2Increased Spending on the EU's External Borders to Drive the Border Security Market, Says Frost & Sullivan 3Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 1Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 2Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 3Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 4Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders 26 Financiers at AdvaMed 2009 57994 5Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 57991 1Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 57991 2Democratic Governors Urge Congress to Act on Health Insurance Reform 57988 1Democratic Governors Urge Congress to Act on Health Insurance Reform 57988 2
... That Cause Cavities and Gum Disease , Blue ... hydrogen peroxide (H 2 O 2 ) combined may be ... biofilms that can cause cavities and gingivitis. The researchers ... California San Francisco report their findings in the July 2008 ...
... continental shelf and drive carbon capture in the deep ocean, ... finding does not change estimates of the oceans, total carbon ... oceans and major rivers. , The tropical North Atlantic had ... of ocean life. A 2007 study estimated that ocean,s contribution ...
... a second strain of the virus, the two viral ... strain of the virus. It is known that ... leads to a loss of immune control of viral ... Research Center at Massachusetts General Hospital (PARC/MGH) shows that ...
Other Biology News:Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3Amazon powers tropical ocean's carbon sink 2Viral recombination another way HIV fools the immune system 2
... StabilGuard Biomolecule Stabilizer is a bovine protein-free ... is an aqueous solution that contains non-toxic ... saline), pH 6.6 - 7.2, and does ... maintains the activity of antibodies and other ...
... The lyophilization stabilizer is designed ... process and for long-term storage. ... toxic ingredients. It is a ... pH 7.2, and is superior to ...
... The CERTOMAT IS, a true benchtop incubator-shaker, ... shakers. Having a footprint of 540 x ... a large incubation chamber (370 x 505 x ... orbits, the CERTOMAT IS is ideal for shaking ...
... smallest thermal cyclers on the market, which is ... (20 samples) or 0.2ml microtube (25 samples) block ... cooling rate of 3.6C/sec and 2.0C/sec respectively ... track programming with new quick dial facility ...
Biology Products: